Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | MERTK |
| Variant | positive |
| Impact List | unknown |
| Protein Effect | unknown |
| Gene Variant Descriptions | MERTK positive indicates the presence of MERTK mRNA and/or protein. |
| Associated Drug Resistance | |
| Category Variants Paths |
MERTK positive |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| MERTK positive | acute lymphoblastic leukemia | sensitive | UNC2025 | Preclinical - Patient cell culture | Actionable | In a preclinical study, UNC2025 inhibited Mertk signaling, resulted in apoptosis and growth inhibition of patient-derived acute lymphocytic leukemia cells in culture, and prolonged survival in orthotopic murine xenograft models (PMID: 27649555). | 27649555 |
| MERTK positive | acute myeloid leukemia | sensitive | UNC2025 | Preclinical - Pdx & cell culture | Actionable | In a preclinical study, UNC2025 inhibited Mertk signaling, resulted in apoptosis and growth inhibition of patient-derived acute lymphocytic leukemia cells in culture, and prolonged survival in patient-derived xenograft models (PMID: 27649555). | 27649555 |
| MERTK positive | acute lymphoblastic leukemia | sensitive | Methotrexate + UNC2025 | Preclinical - Cell line xenograft | Actionable | In a preclinical study, combination of UNC2025 and Methotrexate resulted in improved tumor suppression and survival compared to single agent treatment in cell line xenograft models of acute lymphocytic leukemia (PMID: 27649555). | 27649555 |
| MERTK positive | acute myeloid leukemia | sensitive | UNC569 | Preclinical - Cell culture | Actionable | In a preclinical study, UNC569 inhibited Mertk phosphorylation and downstream signaling, resulted in growth inhibition of acute myeloid leukemia cell lines in culture (PMID: 29277773). | 29277773 |
| MERTK positive | acute myeloid leukemia | sensitive | UNC1062 | Preclinical - Cell culture | Actionable | In a preclinical study, UNC1062 inhibited Mertk phosphorylation and downstream signaling, resulted in growth inhibition of acute myeloid leukemia cell lines in culture (PMID: 29277773). | 29277773 |
| MERTK positive | acute myeloid leukemia | sensitive | UNC1666 | Preclinical - Cell culture | Actionable | In a preclinical study, UNC1666 inhibited Mertk phosphorylation and downstream signaling, induced apoptosis of acute myeloid leukemia cell lines in culture (PMID: 25762638). | 25762638 |
| MERTK positive | Advanced Solid Tumor | predicted - sensitive | RGX-019 | Preclinical - Cell culture | Actionable | In a preclinical study, RGX-019 treatment induced Mertk internalization and degradation in tumor cell lines, leading to inhibition of colony formation in culture (AACR Annual Meeting 2019, Abstract LB-277). | detail... |